Credits will not be given (by ECCMID) for Poster session and Integrated Symposia.

07

08

09

10

11

12

13

14

15

16

17

18

Capital Hall C

09:00 – 11:00

Official Symposium

Controversies in infection control of multidrug-resistant organisms
  • B.D. Cookson (London, GB)
  • D. Gur (Ankara, TR)

11:30 – 12:30

Keynote Lecture

ESCMID Young Investigator Award lectures
  • R.C. Read (Sheffield, GB)

13:30 – 15:30

Official Symposium

Preparing for infectious diseases at the London 2012 Olympic Games
  • G. Cornaglia (Verona, IT)
  • J. McConnell (London, GB)

Capital Hall D

07:45 – 08:45

Meet-the-Expert

Best indicators for measuring the success of hand hygiene …
Best indicators for measuring the success of hand hygiene promotion

09:00 – 11:00

Official Symposium

The epidemiology and clinical relevance of Clostridium difficile in specific populations
  • M. Rupnik (Maribor, SI)
  • E. van Nood (Amsterdam, NL)

11:30 – 12:30

Official Symposium

Does modelling help to predict outbreaks? - PRO/CON debate
  • F. Baquero (Madrid, ES)
  • B.D. Cookson (London, GB)

13:30 – 15:30

Oral session

Bacterial pathogenesis: what is new (from virulence factors to biofilm)?
  • T. Soldati (Geneva, CH)
  • M.-O. Fauvarque (Grenoble, FR)

Capital Suite E

07:45 – 08:45

Meet-the-Expert

Understanding parasite serology

09:00 – 11:00

Abbott Symposium

Weighing the evidence: a new standard in rapid broad microbial identification
  • G. Lina (Lyon, FR)
  • J. Schrenzel (Geneva, CH)

11:30 – 12:30

Official Symposium

Chagas disease 2012: now getting global
  • E. Gotuzzo (Lima, PE)
  • F. Paradisi (Florence, IT)

13:30 – 15:30

Official Symposium

Clinical parasitology in western hospitals: the essentials
  • T. van Gool (Amsterdam, NL)
  • M.J. Alvarez-Martinez (Barcelona, ES)

Capital Suite F

07:45 – 08:45

Meet-the-Expert

CMV infection in critically ill patients

09:00 – 11:00

Official Symposium

MALDI-TOF; what is new?
  • M. Drancourt (Marseille, FR)
  • M. Sundqvist (Växjö, SE)

13:30 – 15:30

Official Symposium

Hot topics in retrovirology
  • J.M. Mirò (Barcelona, ES)
  • B. Hoen (Besançon, FR)

Capital Suite G

07:45 – 08:45

Meet-the-Expert

Infectious complications of new biologic therapies

09:00 – 11:00

Novartis Symposium

Recent advances towards comprehensive prevention of meningococcal disease
  • M.A. Rose (Frankfurt, DE)
  • S. Leib (Berne, CH)

11:30 – 12:30

Keynote Lecture

CMV disease and prevention
  • G. Palù (Padova, IT)

13:30 – 15:30

Oral session

Old and new strategies targeting healthcare associated infections: where do we stand?
  • A. Pan (Cremona, IT)
  • M. Pujol (Barcelona, ES)

Capital Suite H

09:00 – 11:00

DiaSorin Symposium

Diagnostic management of hepatitis B: a new role for HBsAg assay
  • F. Baldanti (Pavia, IT)
  • D. Salmon (Paris, FR)

11:30 – 12:30

Oral Session

Hepatitis
  • K. Seme (Ljubljana, SI)
  • H. Leblebicioglu (Samsun, TR)

13:30 – 15:30

Oral session

Finding better strategies to use antibiotics
  • M. Singer (London, GB)
  • R. Cantòn (Madrid, ES)

Hall N11 A

09:00 – 11:00

Oral session

Understanding pathogenesis and epidemiology by genomics and proteomics
  • C. Tang (London, GB)
  • T. Lawley (Hinxton, GB)

11:30 – 12:30

Official Symposium

Quorum sensing and quorum sensing inhibitors
  • A. Oliver (Palma de Mallorca, ES)
  • M. Lecuit (Paris, FR)

13:30 – 15:30

Official Symposium

Cost efficiency of molecular techniques
  • J. Van Eldere (Leuven, BE)
  • M. Drancourt (Marseille, FR)

Hall N11 B

09:00 – 11:00

Official Symposium

Clinical Grand Round
  • R.C. Read (Sheffield, GB)

11:30 – 12:30

Official Symposium

Common European curricula and assessment: just a dream?
  • M. Akova (Ankara, TR)
  • K. Adams (Hull, GB)

13:30 – 15:30

Oral session

KPC beta-lactamases
  • G.L. Daikos (Athens, GR)
  • A. Carattoli (Rome, IT)

Meeting room 22

13:30 – 15:30

Official Symposium

Flu, mutations and transmission: to publish or not to publish?
  • A.D.M.E. Osterhaus (Rotterdam, NL)
  • P.J.M. Openshaw (London, GB)

Platinum Suite 1/2

09:00 – 11:00

Official Symposium

ISF symposium and presentation of the International Sepsis Forum Award
What's new in sepsis?
  • J. Cohen (Brighton, GB)
  • M. Singer (London, GB)

11:30 – 12:30

oral session

Prevention and therapy of MRSA infection
  • J.A.J.W. Kluytmans (Breda, NL)
  • H. Goossens (Antwerp, BE)

13:30 – 15:30

Official Symposium

Bloodstream infection - epidemiology and management
  • N. Benzonana (Istanbul, TR)
  • W.V. Kern (Freiburg, DE)

Platinum Suite 3/4

07:45 – 08:45

Meet-the-Expert

Fungal taxonomy for the clinician in 2012

09:00 – 11:00

Oral session

HIV infection
  • R. Cauda (Rome, IT)
  • M. Salminen (Stockholm, SE)

11:30 – 12:30

Official Symposium

Developing new antituberculous drugs
  • V. Jarlier (Paris, FR)
  • A. Cingolani (Rome, IT)

13:30 – 15:30

Oral session

Clostridium difficile infection
  • E.J. Kuijper (Leiden, NL)
  • M. Rupnik (Maribor, SI)

07

08

09

10

11

12

13

14

15

16

17

18